|
⚲
|
| Keyboard |
| Equilibria Capital Management Ltd
✚
|
|
|---|---|
| CIK # | 0001724701 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001724701] | |
| 4 | [0001724701] | |
| SC 13D | [0001724701] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Equilibria Capital Management Ltd | Sellas Life Sciences Group Inc | [2018-01-08] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2018-09-24 | Other | 676,324 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2018-09-24 | Other | 1,521,863 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2018-09-24 | Other | 325,799 | $0.00 | |
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2017-12-29 | Grant | 325,799 | ||
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2017-12-29 | Grant | 1,521,863 | ||
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2017-12-29 | Grant | 676,324 | ||
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2017-12-29 | Grant | 149,766 | ||
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2017-12-29 | Grant | 58,208 | ||
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2017-12-29 | Grant | 3,343 | ||
|
SELLAS Life Sciences Group Inc SLS
Common Stock
|
2017-12-29 | Grant | 3,343 | ||
|
SELLAS Life Sciences Group Inc SLS
Warrant (Right to Buy) · derivative
|
2017-12-29 | Grant | 316,163 | $0.00 |